The 14th Annual Dr. Charles I. Jarowski Symposium in Pharmaceutical Sciences
Date: September 25, 2024
Time: 8:30 am- 5:00 pm
Where: D'Angelo Ballroom Room 416ABC
Additional Information
In 2006, three distinguished Pharmacy professionals proposed that they create an alumni group to build support for St. John’s College of Pharmacy and Health Sciences and its Industrial Pharmacy Program. With the goal of inspiring and training the next generation of research scientists, Salah Ahmed ’85GP, ’91Ph.D., Navnit Shah ’73GP, ’81Ph.D. and Abu Serajuddin ’82Ph.D. formed the Industrial Pharmacy Committee.
Together they conceptualized the Dr. Charles I. Jarowski Industrial Pharmacy Symposium, which would act as a dynamic forum for the exchange of information among distinguished research scientists. The Symposium would be an annual event designed to offer our world class alumni the opportunity to explore topics relevant to the changing dynamics within the pharmaceutical industry. It would also act as an opportunity for networking and professional development between students, alumni and industry representatives.
Mansoor Khan, R.Ph. ’92Ph.D. was the first of many distinguished alumni to present at the Jarowski Symposium. He would subsequently become a key member of the Industrial Pharmacy Planning Committee.
Today, the Symposium has evolved into a major event for both the University and distinguished scientists in Pharmacy and the related professions, attracting over 100 participants annually. The theme for the Symposium is chosen by the Industrial Pharmacy Planning Committee each year to reflect the current trends in the pharmaceutical industry.
Each year, selected graduate students in the Industrial Pharmacy Program have the honor of presenting their research findings to attendees, affording them the opportunity to develop their presentation skills, seek career guidance and engage in networking with their peers and world class scientists.
Pharmaceutical industry suppliers and manufacturers also have the opportunity to sponsor the Symposium. In recognition of their support, they are given the chance to set up tables to demonstrate their products and showcase their technology to their key customers, our alumni.
Since its inception, the Dr. Charles I. Jarowski Symposium has become one of the largest academic forums for Industrial Pharmacy in the Northeast.
Coming Soon
Vivek Gupta, Ph.D.
Associate Dean for Graduate Education and Research
Associate Professor, Department of Pharmaceutical Sciences
St. John’s University, NY
Dr. Vivek Gupta is an Associate Professor of Industrial Pharmacy at the College of Pharmacy and Health Sciences. He is an experienced pharmaceutical researcher with interests in developing novel therapies for respiratory disorders. His expertise lies in the fields of novel drug discovery and repurposing, and the noninvasive delivery of small and macromolecules via oral and inhalation routes. He is participating in the Dr. Charles I. Jarowski Industrial Pharmacy Symposium to help students and academic researchers connect with the pharmaceutical industry.
Information coming soon.
| Time | Speaker and Event | Photo |
| 9:30–10 a.m. | Welcoming Remarks Russell J. DiGate, Ph.D. Dean and Professor College of Pharmacy and Health Sciences St. John’s University | |
| 10–11 a.m. | Pieter R. Cullis, Ph.D. Professor University of British Columbia “From Solid-State Physics to Lipid Nanoparticles Enabling COVID-19 Vaccines—a 40-Year Journey” |  |
| 11–11:35 a.m. | Advait Badkar, Ph.D. Senior Director Pfizer Inc. “Pfizer’s Project Lightspeed-Rapid Development of the COVID-19 Vaccine” |  |
| 11:35 a.m.–12:10 p.m. | Vadim Dudkin, Ph.D. Chief Technology Officer Laronde |  |
| 12:10–12:35 p.m. | Devon Langbein Application Laboratory Analytical Scientist Gattefossé “Solubilization, Protection, and Enhancement Mechanisms of Oral Peptides with SEDDS” |  |
| 12:35–1:10 p.m. | Christopher Rhodes, Ph.D. |  |
| 1:10–1:50 p.m. | Lunch and Student Presentations | |
| 1:50–2:25 p.m. | Abir Absar, Ph.D. |  |
| 2:25–3 p.m. | Sarah Johnson, Ph.D. Biologist US Food and Drug Administration “Regulatory Aspects of Antibodies” |  |
| 3–3:25 p.m. | Sean McMahon, Ph.D. Business Development and Technical Manager Ashland “Bioresorbable Polymers in the Delivery Biologics” |  |
| 3:25–3:50 p.m. | Andrea Engel, Ph.D. Director, Innovation Management Birmingham Evonik Industries AG “Excipients for Nanomedicines—an Industrial Perspective” |  |
| 3:50–4:25 p.m. | Tapan K. Das, Ph.D. Senior Director Bristol-Myers Squibb Company “How Critical is Analytics for Biologics Stability?” |  |
| 4:25–5 p.m. | Closing Address and Awards |